Your browser doesn't support javascript.
loading
Exceptional Responses to Selpercatinib in RET Fusion-Driven Metastatic Pancreatic Cancer.
Bhamidipati, Deepak; Yedururi, Sireesha; Huse, Jason; Chinapuvvula, Sri Veda; Wu, Jie; Subbiah, Vivek.
Afiliação
  • Bhamidipati D; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Yedururi S; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Huse J; Department of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Chinapuvvula SV; Medical Science Academy, Hightower High School, Houston, TX.
  • Wu J; Peggy and Charles Stephenson Cancer Center and the Department of Pathology, The University of Oklahoma Health Science Center, Oklahoma City, OK.
  • Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
JCO Precis Oncol ; 7: e2300252, 2023 Sep.
Article em En | MEDLINE | ID: mdl-38039431
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Pirazóis Limite: Humans Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Pirazóis Limite: Humans Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2023 Tipo de documento: Article